Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG); Nigel Bundred; M Dowsett; JF Forbes; R Bradley; J Ingle; T Aihara; J Bliss; F Boccardo; A Coates; RC Coombes; J Cuzick; P Dubsky; M Gnant; M Kaufmann; L Kilburn; F Perrone; D Rea; B Thürlimann; de Velde C van; H Pan; R Peto; C Davies; R. Gray

doi:10.1016/S0140-6736(15)61074-1

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Nigel Bundred, M Dowsett, JF Forbes, R Bradley, J Ingle, T Aihara, J Bliss, F Boccardo, A Coates, RC Coombes, J Cuzick, P Dubsky, M Gnant, M Kaufmann, L Kilburn, F Perrone, D Rea, B Thürlimann, de Velde C vanH Pan, R Peto, C Davies, R. Gray

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	26211827
Pages (from-to)	1341-1352
Number of pages	11
Journal	The Lancet
DOIs	https://doi.org/10.1016/S0140-6736(15)61074-1
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0140-6736(15)61074-1

Cite this

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Bundred, N., Dowsett, M., Forbes, JF., Bradley, R., Ingle, J., Aihara, T., Bliss, J., Boccardo, F., Coates, A., Coombes, RC., Cuzick, J., Dubsky, P., Gnant, M., Kaufmann, M., Kilburn, L., Perrone, F., Rea, D., Thürlimann, B., ... Gray, R. (2015). Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. The Lancet, 1341-1352. Article 26211827. https://doi.org/10.1016/S0140-6736(15)61074-1

@article{523bd7ec63434787a15f4b23f3447c3d,

title = "Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.",

author = "{Early Breast Cancer Trialists' Collaborative Group (EBCTCG)} and Nigel Bundred and M Dowsett and JF Forbes and R Bradley and J Ingle and T Aihara and J Bliss and F Boccardo and A Coates and RC Coombes and J Cuzick and P Dubsky and M Gnant and M Kaufmann and L Kilburn and F Perrone and D Rea and B Th{\"u}rlimann and van, {de Velde C} and H Pan and R Peto and C Davies and R. Gray",

year = "2015",

doi = "10.1016/S0140-6736(15)61074-1",

language = "English",

pages = "1341--1352",

journal = "The Lancet",

issn = "1474-547X",

publisher = "Elsevier BV",

}

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Bundred, N, Dowsett, M, Forbes, JF, Bradley, R, Ingle, J, Aihara, T, Bliss, J, Boccardo, F, Coates, A, Coombes, RC, Cuzick, J, Dubsky, P, Gnant, M, Kaufmann, M, Kilburn, L, Perrone, F, Rea, D, Thürlimann, B, van, DVC, Pan, H, Peto, R, Davies, C & Gray, R 2015, 'Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.', The Lancet, pp. 1341-1352. https://doi.org/10.1016/S0140-6736(15)61074-1

TY - JOUR

T1 - Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

AU - Early Breast Cancer Trialists' Collaborative Group (EBCTCG)

AU - Bundred, Nigel

AU - Dowsett, M

AU - Forbes, JF

AU - Bradley, R

AU - Ingle, J

AU - Aihara, T

AU - Bliss, J

AU - Boccardo, F

AU - Coates, A

AU - Coombes, RC

AU - Cuzick, J

AU - Dubsky, P

AU - Gnant, M

AU - Kaufmann, M

AU - Kilburn, L

AU - Perrone, F

AU - Rea, D

AU - Thürlimann, B

AU - van, de Velde C

AU - Pan, H

AU - Peto, R

AU - Davies, C

AU - Gray, R.

PY - 2015

Y1 - 2015

U2 - 10.1016/S0140-6736(15)61074-1

DO - 10.1016/S0140-6736(15)61074-1

M3 - Article

SN - 1474-547X

SP - 1341

EP - 1352

JO - The Lancet

JF - The Lancet

M1 - 26211827

ER -